Surgical Management of the Patients with Liver Metastases of Pancreatic Neuroendocrine Tumors Abstract #835

Introduction: Most pancreatic neuroendocrine tumors (PNET) grow slowly but around 60% of the patients have distant metastases. Although new drugs have recently emerged, surgical resection is still one of the key modalities for curing the tumor.
Aim(s): To elucidate the tumor categories which get the most benefit from surgical resection of the metastases, we examine the efficacy of the surgical resection of the PNET distant metastases on survival.
Materials and methods: From 1992 to 2012, 121 PNET patients were treated at our hospital. Of these, there were 16 patients who had recurrences after curative resection and 22 patients with distant metastasis at their first admission. We analyzed the progression-free survival as well as overall survival of the resected patients.
Conference: 11th Annual ENETS Conference 2014 (2014)
Category: Surgical treatment
Presenting Author: M.D., Ph.D. Toshihiko Masui

To read results and conclusion, please login ...

Further abstracts you may be interested in

#2961 Our Experience Using a New Scoring System to Detect Disease Recurrence after Curative Surgical Resection of Well-Differentiated Pancreatic Neuroendocrine Tumors
Introduction: For patients with nonfunctioning pNET  ≥20 mm in size without distant metastasis, complete surgical resection is recommended as the primary curative strategy. Effective follow‐up programs are designed to detect recurrence at an early stage, given that treatment of limited disease has the most favorable outcome. However, data on post‐curative surgical recurrence remains limited, making it challenging to determine the best follow‐up strategy and to detect the best treatment options as an adjuvant therapy for selected patients.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Surgical treatment and Ablative Therapies
Presenting Author: MD Laura Mastrangelo
#2886 Risk Factors for Short Recurrence-Free Survivals after Resection of PanNET Liver Metastasis: Single Institutional Analysis
Introduction: Although the treatment of PanNEN has improved survivals with development of pharmacotherapy recently, surgery is the first choice if curative resection is expected to be achieved. However, most of the patients undergo recurrence after resection of the liver metastasis even after curative resection. Therefore, it is important to identify who gains longer RFS by resection.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Surgical treatment and Ablative Therapies
Presenting Author: M.D., Ph.D. Toshihiko Masui
Authors: Masui T, Anazawa T, Nagai K, Sato A, ...
#2700 Pancreatic Neuroendocrine Neoplasms and Liver Metastases: When Size Matters
Introduction: Small non-functioning pNENs are low grade indolent tumors, however distant metastases have also been documented in this subset of patients
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Surgical treatment and Ablative Therapies
Presenting Author: MD Michela Monteleone
#1071 Pathological Factors Predicting Recurrence of the Non-Functioning Pancreatic NET after Resection
Introduction: The usefulness of the WHO 2010 classification for surgeons has not been elucidated, since the criteria is defined by cell growth with Ki67 and may not represent invasiveness of the tumor as well as the recurrence type (liver metastasis or lymph node metastasis)
Conference: 12th Annual ENETS Conference 2015 (2015)
Category: Surgical treatment
Presenting Author: M.D., Ph.D. Toshihiko Masui
Authors: Masui T, Sato A, Takaori K, Uemoto S, ...
#1464 A Case of Multiple Pancreatic Insulinoma Laparoscopically Resected through Precise Spatial Diagnosis by SACI Test
Introduction: Case: A 58-year-old man representing cold sweat, palpitation and nausea was admitted to our hospital and was pointed out parathyroid, pancreatic and superior mediastinal masses with CT.
Conference: 13th Annual ENETS conference 2016 (2016)
Category: Clinical cases/reports
Presenting Author: Kenzo Nakano
Authors: Nakano K, Masui T, Sato A, Ito T, ...